Showing 4,481 - 4,500 results of 5,876 for search '"Medication"', query time: 0.10s Refine Results
  1. 4481
  2. 4482
  3. 4483
  4. 4484
  5. 4485
  6. 4486
  7. 4487
  8. 4488
  9. 4489
  10. 4490

    Phase 1 study of novel anti-platelet agent to overcome pharmacogenomic limitations of clopidogrel by Anil Pareek, Nitin Chandurkar, Vivek Raut, Kumar Naidu

    Published 2025-02-01
    “…It can be further developed in clinical studies for the unmet medical needs in management of CVDs and overcome the pharmacogenomic limitations of Clopidogrel.Trial registration number Clinical Trial Registry-India URL: http://ctri.nic.in. …”
    Get full text
    Article
  11. 4491
  12. 4492
  13. 4493

    Using a Two-Steps Clustering and PCA Analysis for Stratified Chronic Non-Cancer Pain Care: A Retrospective Cross-Sectional Study by Peiró AM, Barrachina J, Escorial M, Aguado I, Margarit C, Grimby-Ekman A

    Published 2025-02-01
    “…Being older than 65 years old, retired or on medical leave, under opioids and anxiolytic prescription, had a severe impact on daily quality of life without any sex-difference.Conclusion: These clusters based on real-world clinical information might be useful for screening even more where the access to physical exploration is limited. …”
    Get full text
    Article
  14. 4494
  15. 4495
  16. 4496
  17. 4497

    Factors Influencing Background Parenchymal Enhancement in Breast Contrast-Enhanced Mammography: A Retrospective Study by Xue J, Qu T, Li Z, Shi B, Yang G, Rong X, Li Y, Lin G, Ping Y

    Published 2025-02-01
    “…Jing Xue,1 Tianyun Qu,1 Zhigang Li,1 Bo Shi,1 Guang Yang,1 Xiaocui Rong,1 Yazhou Li,1 Guoquan Lin,2 Yong Ping1 1Department of Radiology; Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People’s Republic of China; 2Department of General Surgery; Botou Hospital, Cangzhou City, Hebei Province, 062150, People’s Republic of ChinaCorrespondence: Yong Ping, Email Ulrica150sci@163.comObjective: To evaluate the association between background parenchymal enhancement (BPE) level and extent on contrast-enhanced mammography (CEM) with age, menopausal status, breast density, and menstrual cycle phase in women. …”
    Get full text
    Article
  18. 4498
  19. 4499
  20. 4500